CI vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 16, 2026

CI

64.5
AI Score
VS
CI Wins

CLOV

54.6
AI Score

Investment Advisor Scores

CI

65score
Recommendation
BUY

CLOV

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CI CLOV Winner
Forward P/E 9.4877 81.9672 CI
PEG Ratio 0.8623 0 Tie
Revenue Growth 4.6% 62.0% CLOV
Earnings Growth 29.1% 0.0% CI
Tradestie Score 64.5/100 54.6/100 CI
Profit Margin 2.3% -2.6% CI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CI

Frequently Asked Questions

Based on our detailed analysis, CI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.